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Child-focused health care workers are compelled to prescribe 
medicines that lack adequate dosage guidelines for children, as dosing 
is often derived from data extrapolated from adult studies.1-3 Given 
that the pharmacokinetics and pharmacodynamics of treatments 
are often unknown for children, and that effectiveness may vary 
according to age, developmental stage and body size, there is an 
urgent need to study diagnostic and therapeutic interventions in 
children to increase the evidence base.4-7 A 2005 report of African 
HIV trial activity identified 77 randomised controlled HIV/AIDS 
trials prior to 2004.8 Analysis revealed poor representation of 
children and adolescents.9 Currently there is no database dedicated 
to collating child-focused clinical research for the African continent. 
Our aim is to summarise evolving efforts for such a resource.
Before the launch of the Pan African Clinical Trials Registry 
(PACTR) (www.pactr.org) in September 2009, there was no concerted 
effort among African nations to collect and monitor information on 
trial activity in any formalised and cohesive manner. The PACTR 
was developed in response to this need and aims to increase clinical 
trial registration in Africa through its user-friendly open-access 
repository. PACTR is currently the only African member of the 
World Health Organization (WHO)’s Network of Primary Registries. 
This expanding initiative provides data to the International Clinical 
Trials Registry Platform (ICTRP), thereby increasing visibility of 
African clinical trials.10,11
Combining the lack of trial registration repositories in Africa with 
the paucity of research globally on interventions and medications for 
children,12,13  there is clearly a need to develop a better understanding 
of the clinical trial landscape in the region, especially for infants and 
children. In October 2009, the PACTR initiated the Africa-region 
Child Strategy, partnering with the WHO and complementing its 
ongoing activities.
In December 2009, the Child Strategy was formally launched as a 
sub-project of the PACTR (www.pactr.org). The Strategy’s objectives 
include developing an awareness of the global and continental need 
to register and conduct paediatric clinical trial research within 
the region, encouraging trials in the region to include children as 
participants, and increasing the number of registered trials enrolling 
children in Africa. Presentations at relevant conferences and agenda-
setting meetings have increased awareness of these activities.14,15
The registry staff developed a database of child-focused 
stakeholders in Africa aiming to facilitate networking of researchers, 
funders, institutions, non-profit organisations, development agencies 
and policymakers. The main purpose is to increase collaboration 
and information sharing through regular communication and 
future collaborative meetings. The Child Strategy’s dedicated Special 
Interest Group advises on the development of the research network 
and focused advocacy activities.
Trialists are encouraged to register in the first WHO-endorsed 
primary registry on the African continent, thus helping to fill in gaps 
about knowledge of African trial activity. The initiative continues 
to look for opportunities to disseminate these important activities 
further and looks to readers, and stakeholders, to inform us of 
venues through which this can be done. We welcome input. Those 
interested in becoming involved in the Child Strategy or seeking 
more information about the PACTR or the Child Strategy should visit 
the registry website www.pactr.org.
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